Money
Nike hit with lawsuit over tariff surcharges as consumers demand refunds
The case could become a major test of whether companies that passed tariff costs to consumers must return the money if those tariffs are later invalidated
Latest
Health
FDA opens door to flavored vapes, alarming anti-smoking advocates
Public-health groups warn the move could reignite youth vaping after years of declines in teen e-cigarette use
Iran war reshapes the American household budget as five pressures collide
Top consumer stories: May 11, 2026 Eleven weeks into a war with Iran that no one expected to last this long, the conflict is now the through-line of the American consumer story. It has pushed gasoline 52 percent higher than it was in late February, lifted mortgage rates back
Health
‘Low T’ boom raises concerns over overdiagnosis, aggressive marketing to men
Testosterone prescriptions are surging as private clinics, influencers and social media campaigns promote “low T” as a hidden cause of fatigue, weight gain and low libido
Money
Five squeezes, one wallet: The pressures hitting U.S. consumers this week
American consumers are walking into the second week of May juggling a tighter set of trade-offs than at any point this year.
Five squeezes, one wallet: The pressures hitting U.S. consumers this week
American consumers are walking into the second week of May juggling a tighter set of trade-offs than at any point this year.
Money
Court ruling could force IRS to refund pandemic-era late fees to millions
The case is still in court but taxpayers should file a protective refund request now
AI/Privacy
GM to pay $12.75m to settle California claims it sold drivers’ location data to brokers
The company sold data it collected through its OnStar service
Health
Delays in EpiPen Use Drive Fatal Anaphylaxis in Children, New Studies Find
Having a prescription isn't enough. Patients need to have the EpiPen with them.
Health
GLP-1 Drug Lawsuits Swell Past 3,600 Cases as Courts Tighten Proof Standards
The cases involve Ozempic, Wegovy, Mounjaro, Zepbound and Trulicity Federal litigation over the blockbuster class of GLP-1 drugs that includes Ozempic, Wegovy, Mounjaro, Zepbound and Trulicity has ballooned to more than 3,600 pending cases across two multidistrict proceedings, as a federal judge moves to tighten the medical evidence
Lawsuits against GLP-1 drugmakers surge over alleged failure to warn about serious side effects
Thousands of lawsuits have been filed against makers of blockbuster GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound
Recalls
Safety Recalls May 8, 2026
Take a quick look to see if any apply to you